So, some resistance trends are improving, but others, such as the rise in ESBL-producing Enterobacterales and hospital-associated infections during the COVID-19 pandemic, are concerning. This warrants caution in prescribing antibiotics, particularly 3rd-gen CPH and carbapenems.